GregoryMRiedlingerMD
Pathology • New Brunswick, NJMolecular Genetics, Anatomic Pathology, Clinical Pathology
Physician
Are you Dr. Riedlinger?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Connect with colleagues in the same hospital or clinic
You already have 17 invites waiting! - Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
195 Little Albany St, Room #3553
Department of Translational Pathology
New Brunswick, NJ 08903Phone+1 732-235-8978- Is this information wrong?
Summary
- Dr. Gregory Riedlinger, MD is a board certified pathologist in New Brunswick, New Jersey. He is currently licensed to practice medicine in New Jersey, Maryland, and Massachusetts. He is affiliated with Robert Wood Johnson University Hospital.
Education & Training
National Institutes of Health Clinical CenterResidency, Pathology-Anatomic and Clinical, 2010 - 2013
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2009
Certifications & Licensure
NJ State Medical License 2015 - 2025
PA State Medical License 2013 - 2016
MA State Medical License 2013 - 2014
MD State Medical License 2013 - 2013- American Board of Pathology Pathology - Anatomic
- American Board of Pathology Pathology - Molecular Genetic
Publications & Presentations
PubMed
- 2 citationsSmoking-associated Downregulation of FILIP1L Enhances Lung Adenocarcinoma Progression Through Mucin Production, Inflammation, and Fibrosis.Mijung Kwon, Genesaret Rubio, Haitao Wang, Gregory Riedlinger, Asha Adem, Hua Zhong, Daniel Slegowski, Louisa Post-Zwicker, Anshruta Chidananda, David S Schrump, Sharo...> ;Cancer Research Communications. 2022 Oct 1
- 7 citationsGenomic landscape of lymphatic malformations: a case series and response to the PI3Kα inhibitor alpelisib in an-of-1 clinical trial.Montaser F Shaheen, Julie Y Tse, Ethan S Sokol, Margaret Masterson, Pranshu Bansal, Ian Rabinowitz, Christy A Tarleton, Andrey S Dobroff, Tracey L Smith, Thèrése J Boc...> ;Elife. 2022 Jul 5
- 91 citationsReal-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers.M Palmeri, J Mehnert, A W Silk, S K Jabbour, S Ganesan, P Popli, G Riedlinger, R Stephenson, A B de Meritens, A Leiser, T Mayer, N Chan, K Spencer, E Girda, J Malhotra...> ;ESMO Open. 2022 Feb 1
- Join now to see all
Press Mentions
Solid Tumor Genomic Sequencing Can Reveal Coexistent Hematologic MalignancyJanuary 2nd, 2019- CHIPing Away at Cancer Tumors Through Genomic AnalysisApril 23rd, 2018
Hospital Affiliations
Robert Wood Johnson University HospitalNew Brunswick, New Jersey
